Login to Your Account



Phase I Clinical Trials Update: November 2011


Monday, December 12, 2011

Company (Location)

Product

Description

Indication

Status (Date)#


CANCER

Bavarian Nordic A/S (Kvistgard, Denmark)

CV-301

Off-the-shelf immunotherapy

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription